Vitarka Therapeutics Ltd
Company Profile
live
MicroVitarka Therapeutics Ltd
13291464•Private Limited With Share Capital
Innovation House Innovation Way, Discovery Park, Sandwich, CT139FF
Get Full Access
Incorporated
25/03/2021
Company Age
5 years
Directors
3
Employees
2
SIC Code
72110
Risk
very low risk
Company Overview
Registration, classification & business activity
Vitarka Therapeutics Ltd (13291464) is a private limited with share capital incorporated on 25/03/2021 (5 years old) and registered in sandwich, CT139FF. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Private Limited With Share Capital
SIC: 72110
Micro
Incorporated 25/03/2021
CT139FF
2 employees
Financial Overview
Total Assets
£436.7K
Liabilities
£17.7K
Net Assets
£419.0K
Cash
£403.7K
Key Metrics
2
Employees
3
Directors
6
Shareholders
1
PSCs
Board of Directors
3
Name
Position
Filed Documents
39
Document Name
Category
Date
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:21-04-2026
Replacement Filing Of Director Appointment With Name
Category:Officers
Date:20-04-2026
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:19-09-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:04-04-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:04-04-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:19-08-2024
Capital Cancellation Shares
Category:Capital
Date:22-04-2024
Capital Return Purchase Own Shares
Category:Capital
Date:22-04-2024
Capital Cancellation Shares
Category:Capital
Date:15-04-2024
Capital Return Purchase Own Shares
Category:Capital
Date:15-04-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:09-04-2024
Resolution
Category:Resolution
Date:13-03-2024
Capital Name Of Class Of Shares
Category:Capital
Date:13-03-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:11-03-2024
Second Filing Capital Allotment Shares
Category:Capital
Date:03-10-2023
Capital Allotment Shares
Category:Capital
Date:26-09-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:08-09-2023
Resolution
Category:Resolution
Date:29-08-2023
Change Person Director Company With Change Date
Category:Officers
Date:19-07-2023
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:31-05-2023
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:28-04-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:17-04-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:07-04-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:07-04-2023
Resolution
Category:Resolution
Date:23-01-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:20-01-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:14-12-2022
Resolution
Category:Resolution
Date:26-10-2022
Memorandum Articles
Category:Incorporation
Date:26-10-2022
Capital Allotment Shares
Category:Capital
Date:24-10-2022
Second Filing Capital Allotment Shares
Category:Capital
Date:12-10-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:15-06-2022
Capital Allotment Shares
Category:Capital
Date:21-04-2022
Capital Alter Shares Subdivision
Category:Capital
Date:21-04-2022
Resolution
Category:Resolution
Date:21-04-2022
Memorandum Articles
Category:Incorporation
Date:21-04-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:07-04-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:02-07-2021
Incorporation Company
Category:Incorporation
Date:25-03-2021
Innovate Grants
3
This company received a grant of £455000.0 for Rnaopore: Tumour Targeted Non-Viral Delivery For Rna Therapeutics. The project started on 01/04/2023 and ended on 30/09/2024.
This company received a grant of £50000.0 for Endo-Pore: Targeted Non-Viral Cytoplasmic Delivery Of Nucleic-Acid Therapies. The project started on 01/11/2022 and ended on 28/02/2023.
+1 more grants available
Risk Assessment
very low risk
International Score
Future Factor
good
Performance Rating
Accounts
Typetotal exemption full
Due Date30/09/2026
Filing Date19/09/2025
Latest Accounts31/12/2024
Trading Addresses
124 City Road, City Road, London, EC1V2NX
Innovation House, Innovation Way, Discovery Park, Sandwich, CT139FFRegistered
Related Companies
2
Contact
vitarka.co.uk
Innovation House Innovation Way, Discovery Park, Sandwich, CT139FF